Recombinant human thrombopoietin mimetics (Shandong Quangang)
血小板生成素拟肽（山东泉港）
Report date: 2026/03/20 20:03:07
Base Information
Drug NameRecombinant human thrombopoietin mimetics (Shandong Quangang)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShandong Quangang Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShandong Quangang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A